Interferon-β mutants with increased anti-proliferative activity
US8052964B2 · kind B2 · utility
5Cited by
53References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2008 |
| Grant date | Nov 8, 2011 |
| Priority date | — |
| Expiry date | Apr 9, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Protease resistant modified interferon-beta polypeptides, pharmaceutical compositions and methods of treatment by administering the compositions are provided. The modified interferon-beta polypeptides are orally available; hence pharmaceutical compositions formulated for oral administration also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.